156 related articles for article (PubMed ID: 30260476)
1. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract][Full Text] [Related]
2. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
3. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
4. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
5. A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.
Bennett G; Sadlier D; Doran PP; Macmathuna P; Murray DW
BMC Cancer; 2011 Feb; 11():50. PubMed ID: 21284875
[TBL] [Abstract][Full Text] [Related]
6. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.
Naito Y; Sakamoto N; Oue N; Yashiro M; Sentani K; Yanagihara K; Hirakawa K; Yasui W
Cancer Sci; 2014 Feb; 105(2):228-35. PubMed ID: 24283360
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells.
Nummela P; Lammi J; Soikkeli J; Saksela O; Laakkonen P; Hölttä E
Am J Pathol; 2012 Apr; 180(4):1663-74. PubMed ID: 22326753
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.
Wen G; Hong M; Li B; Liao W; Cheng SK; Hu B; Calaf GM; Lu P; Partridge MA; Tong J; Hei TK
Int J Oncol; 2011 Oct; 39(4):1001-9. PubMed ID: 21701776
[TBL] [Abstract][Full Text] [Related]
10. PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.
Ueta K; Otowa Y; Kakeji Y; Hirashima M
Anticancer Res; 2018 Nov; 38(11):6139-6145. PubMed ID: 30396930
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
Sato T; Muramatsu T; Tanabe M; Inazawa J
Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
[TBL] [Abstract][Full Text] [Related]
12. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
13. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
15. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer.
Gu Z; Li Y; Yang X; Yu M; Chen Z; Zhao C; Chen L; Wang L
J Hematol Oncol; 2018 Sep; 11(1):115. PubMed ID: 30217218
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression.
Rudra-Ganguly N; Lowe C; Mattie M; Chang MS; Satpayev D; Verlinsky A; An Z; Hu L; Yang P; Challita-Eid P; Stover DR; Pereira DS
PLoS One; 2014; 9(11):e111515. PubMed ID: 25369402
[TBL] [Abstract][Full Text] [Related]
19. SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells.
Cao K; Xie D; Cao P; Zou Q; Lu C; Xiao S; Zhou J; Peng X
Oncol Res; 2014; 21(5):271-9. PubMed ID: 24854103
[TBL] [Abstract][Full Text] [Related]
20.
Seok Y; Lee WK; Park JY; Kim DS
Mol Cells; 2019 Feb; 42(2):161-165. PubMed ID: 30726660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
